Life Science Company News

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment

Read more ››
By: GlobeNewswire - 02 May 2024

Aanastra Inc to Showcase its Peptide-RNA Therapeutics Technology in Multiple Presentations at the American Society for Gene and Cell Therapies (ASGCT) Annual Meeting 2024

Read more ››
By: GlobeNewswire - 02 May 2024

SpringWorks Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates

Read more ››
By: GlobeNewswire - 02 May 2024

Regeneron Reports First Quarter 2024 Financial and Operating Results

Read more ››
By: GlobeNewswire - 02 May 2024

Reunion Neuroscience Inc. Announces $103 Million Series A Financing Co-Led by MPM BioImpact and Novo Holdings

Read more ››
By: GlobeNewswire - 02 May 2024

Axogen, Inc Reports First Quarter 2024 Financial Results

Read more ››
By: GlobeNewswire - 02 May 2024

Arvinas to Present at Upcoming Investor Conferences

Read more ››
By: GlobeNewswire - 02 May 2024

Pneumagen to Present Phase 2 Clinical Data on Neumifil, its Broad-Spectrum Antiviral, Intranasal Drug for Viral Respiratory Tract Infections, at ATS 2024

Read more ››
By: GlobeNewswire - 02 May 2024

Quell Therapeutics Highlights Clinical Potential of QEL-001 and its Multi-Modular Treg Cell Therapy Platform at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

Read more ››
By: GlobeNewswire - 02 May 2024

BridgeBio launches BridgeBio Oncology Therapeutics (BBOT) with $200M of private external capital to accelerate the development of its novel precision oncology pipeline

Read more ››
By: GlobeNewswire - 02 May 2024

Athira Pharma to Participate in Upcoming May Conferences

Read more ››
By: GlobeNewswire - 02 May 2024

Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis

Read more ››
By: GlobeNewswire - 02 May 2024

Chemomab Therapeutics to Present at 2024 Aegis Virtual Conference

Read more ››
By: GlobeNewswire - 02 May 2024

Tilray Brands Launches XMG Zero, a New ‘Better for You’ Cannabis Beverage

Read more ››
By: GlobeNewswire - 02 May 2024

ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024

Read more ››
By: GlobeNewswire - 02 May 2024

Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting

Read more ››
By: GlobeNewswire - 02 May 2024

Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment

Read more ››
By: GlobeNewswire - 02 May 2024

Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events

Read more ››
By: GlobeNewswire - 02 May 2024

Agios Reports Business Highlights and First Quarter 2024 Financial Results

Read more ››
By: GlobeNewswire - 02 May 2024

Matinas BioPharma to Webcast Conference Call to Discuss First Quarter 2024 Financial Results and Provide a Business Update on May 9, 2024

Read more ››
By: GlobeNewswire - 02 May 2024
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate